Stay updated on Venetoclax and Novel Agents in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T01:56:41.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T22:39:47.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:18:57.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T19:11:09.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has removed a detailed section regarding data download options and fields related to clinical study information.
    Difference
    14%
    Check dated 2024-11-23T05:46:23.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    New content was added on November 13, 2024, while previous content was removed on October 10, 2024.
    Difference
    0.6%
    Check dated 2024-11-16T01:24:46.000Z thumbnail image

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.